Peptide science · Parker, Colorado
Explore the science. Understand the possibilities.
Peptides are small chains of amino acids involved in the body’s signaling systems. Researchers are exploring their roles in body composition, skin health, inflammation, and tissue repair. Here’s a clear look at the proposed benefits and what the evidence shows so far.
Start with your goals
Curiosity deserves a thoughtful conversation.
Whether your interests are recovery, body composition, or skin health, understanding the research helps you ask better questions. We look at the exact peptide, the people or models studied, and how a finding might relate to your health. This page is educational; our team can discuss which care options are appropriate and available.
Human clinical researchTesamorelin
Research focus: visceral fat and metabolic health.
Tesamorelin stimulates growth hormone release. Randomized trials in specific patient populations have shown reductions in visceral fat—the fat around internal organs. Smaller studies have also explored liver fat and metabolic markers.
Results depend on the population studied. Researchers have also studied selected adults with obesity and reduced growth hormone secretion. These findings do not establish general weight-loss benefits, and changes in visceral fat do not necessarily mean a lower number on the scale.
Read the visceral-fat trial ↗Explore metabolic research ↗
Early human studiesSermorelin
Research focus: growth hormone signaling and healthy aging.
Sermorelin is a growth hormone–releasing hormone fragment studied for its ability to stimulate the body’s own growth hormone release. Areas of interest include muscle function, body composition, and cognitive aging.
A small six-week study in older men found increased nighttime growth hormone release and improvements in selected strength measures, with no change in measured body composition. Early cognitive studies have also reported signals worth exploring. Larger trials are needed to establish meaningful long-term benefits.
Read the muscle-function study ↗Explore cognitive-aging research ↗
Hormonal and clinical researchIpamorelin
Research focus: growth hormone release and recovery pathways.
Ipamorelin acts at the ghrelin receptor and has stimulated growth hormone release in human volunteer studies. This has generated interest in whether hormonal effects could translate into changes in body composition or recovery.
Human studies have measured growth hormone responses. Whether those changes improve body composition or everyday recovery remains an open research question.
Read the human hormone study ↗
Understanding combination formulas
Compounding peptides
GLOW, KLOW, and Wolverine are names used for peptide blends. These names commonly refer to different combinations of GHK-Cu, BPC-157, TB-500, and/or KPV. Ingredients and concentrations vary by source, so the actual formula matters more than the nickname.
GLOW
A name commonly used for a combination of GHK-Cu, BPC-157, and TB-500. Interest centers on skin-related biology and tissue-repair pathways studied for the individual ingredients.
KLOW
Often described as a GLOW-style blend with KPV added, bringing together interest in tissue repair, skin health, and inflammatory signaling.
Wolverine
Commonly used for a BPC-157 and TB-500 combination, usually discussed in relation to connective-tissue and recovery research.
These are descriptions of common naming conventions, not standardized prescriptions. Research on individual ingredients does not establish the effectiveness, compatibility, or safety of a finished blend.
A closer look at the ingredients
What is each peptide being studied for?
Skin and connective-tissue biologyGHK-Cu
Proposed benefits: support for collagen formation, skin remodeling, and wound repair.
Laboratory and animal studies have examined collagen production and connective-tissue accumulation. Topical wound-healing research is also being explored in people. The formulation and route matter: findings from a skin product cannot establish the effects of an injected blend.
Collagen research ↗Animal wound research ↗
Predominantly preclinical researchBPC-157
Proposed benefits: tendon, ligament, and soft-tissue repair, with additional interest in gastrointestinal protection.
Animal studies have reported improvements in tendon and ligament healing, while cell studies explore how repair-related cells move and respond to signals. These findings explain the interest in BPC-157; reliable human trials are needed to determine whether similar benefits occur in patients.
Animal tendon-healing study ↗Animal ligament-healing study ↗
Cell-migration and tissue-repair pathwaysTB-500
Proposed benefits: tissue repair and recovery through pathways involved in cell movement and wound healing.
TB-500 is marketed in relation to thymosin beta-4 biology. Research on full-length thymosin beta-4 includes laboratory work and early human studies of topical wound treatment. Products labeled TB-500 may differ in their peptide form; those studies do not establish that a TB-500 injection or blend produces the same results.
Read the topical thymosin beta-4 trial ↗
Inflammation and intestinal-barrier researchKPV
Proposed benefits: modulation of inflammatory signaling and support for intestinal-barrier health.
KPV is a three-amino-acid fragment associated with alpha-melanocyte-stimulating hormone. Cell and mouse studies have shown reduced inflammatory signaling and improvement in experimental colitis. Current research questions include delivery methods and whether these findings can translate into useful human treatments.
Cell and animal inflammation study ↗Explore delivery-system research ↗
Following the science
What comes next in peptide research?
Important questions include which patients may benefit, how best to deliver a peptide, whether combinations add value, and how to measure long-term outcomes. Well-designed human trials help turn promising biological findings into practical medical knowledge.
Research to follow: topical GHK-Cu
A registered study is examining GHK-Cu gel for healing small, standardized skin wounds. A trial registration describes a research plan; it does not establish a treatment benefit.
View the study record and current status ↗How do we decide whether a peptide is appropriate?
We start with your health history and goals, then review the specific preparation, route, evidence, potential adverse effects, medication interactions, monitoring, and costs. Some peptides discussed here remain investigational. Tesamorelin’s approved use is specific to HIV-associated abdominal fat accumulation; that does not establish general weight-loss or anti-aging benefits.
Many peptide preparations and blends discussed online are not FDA approved. Product quality and long-term human safety data vary. Research-only products should not be used for self-treatment.
Are peptides included in concierge membership?
Specialized treatments and medications may involve separate costs. Ask our team to confirm available options, evaluation, monitoring, and pricing.
Where can I learn about weight-management medicines?
Our medical weight-loss page explains semaglutide and tirzepatide and separates current treatment options from investigational research.
Research reviewed October 20, 2026. Study links are provided beside the relevant findings. Proposed benefits describe research interests, not promised results.